Delta 9 Cannabis Inc. (OTCQX:DLTNF) (TSX DN) has entered into an agreement with Research Capital Corporation as sole agent and sole bookrunner, in connection with an overnight marketed public offering of units of the company at an indicative price of $0.22 per unit, priced in the context of the market, for gross proceeds of approximately $2 million.
Each unit shall be comprised of one common share of the company and one common share purchase warrant of the company. Each warrant shall entitle the holder thereof to purchase one common share at an indicative exercise price of $0.255 per common share, priced in the context of the market, for a period of 36 months following closing of the offering.
